Sohang Chatterjee
 | This article has multiple issues. Please help improve it or discuss these issues on the talk page. (Learn how and when to remove these messages)
|
Sohang Chatterjee | |
|---|---|
| Born | |
| Nationality | Indian |
| Occupation(s) | Scientist and Entrepreneur |
| Known for | Co-founder and CEO of Zumutor Biologics Inc., Boston, USA, Co-Founder and CEO of Theramyt Biologics Private Limited, Bangalore, India., Co-founder and CEO of Inbiopro Solutions Private Limited, Bangalore, India. |
Sohang Chatterjee is an Indian-born scientist/entrepreneur who has co-founded two biotech companies and expanded the recent company's operations in the USA.[1][2]
Education
[edit]Chatterjee holds a B.Sc. degree in Microbiology, Chemistry and Botany from St. Joseph's College, Bangalore, India (1992). He completed his master's in molecular biology from Tata Institute of Fundamental Research, Bangalore, (1995). He then undertook research at Cornell University, New York, USA, and SUNY Buffalo (1995–2000).[3]
Career
[edit]Chatterjee has experience in various scientific fields.[4][5] In 2000, he was the Group Leader at Millipore India (P) Ltd., Bangalore until June 2006.[6] From July 2006 till May 2007, he was the Division Head at Avestha Gengraine Technologies (P) Ltd., Bangalore.[3]
In June 2007, Chatterjee co-founded Inbiopro Solutions Private Limited, Bangalore, India and subsequently became its CEO and Director till November 2012 when Inbiopro was sold.[7][8][9][10] In July 2013, Chatterjee co-founded Theramyt Biologics Private Limited, Bangalore and became its Director and CEO.[11][12][13]
In June 2015, Chatterjee co-founded Zumutor Biologics Inc.; ( an associate of Theramyt)[14] He has presented several scientific papers and also has a number of patents filed in the areas of monoclonal antibody discovery and modification to enhance their potency.[3]
Chatterjee is a member of ABLE (Association of Biotechnology Led Enterprises) in India and continues to be a jury member and mentor for the various start-up programs supported by ABLE in India since 2013.[3] As a charter member of TiE in Boston, he is actively involved in contributing to biotechnology entrepreneurship and organizational development of young start-ups.[3]
References
[edit]- ^ "Theramyt Novobiologics raises $4.4M from Aarin, Accel and IDG". vccircle.com. 11 October 2013. Retrieved 14 October 2016.
- ^ "Theramyt lab facility inaugurated in Bangalore". daijiworld.com. 31 January 2014. Retrieved 14 October 2016.
- ^ a b c d e "Founding team". theramyt.com. Retrieved 14 October 2016.
- ^ Amit, Tiwari (25 February 2016). "Notable Indian Startups in Biotech Space!". techstory.in. Retrieved 14 October 2016.
- ^ "Biopharma company Theramyt Novobiologics raises Rs 27.5 crore". Economic Times. 11 October 2013. Archived from the original on 27 March 2014. Retrieved 14 October 2016.
- ^ "India's hottest start-ups". businesstoday.in. 22 March 2009. Retrieved 14 October 2016.
- ^ "Strides Arcolab buys 70% in biotech start-up Inbiopro". thehindubusinessline.com. Retrieved 14 October 2016.
- ^ "Identifying committed core team crucial". biospectrumindia.com. Retrieved 14 October 2016.
- ^ Rahul, Sachitanand (26 June 2011). "Spot on, mostly". businesstoday.in. Retrieved 14 October 2016.
- ^ "Strides snaps up Inbiopro Solutions Agencies". indianexpress.com. 9 December 2010. Retrieved 14 October 2016.
- ^ "Theramyt Novobiologics investing $10M by 2015 to develop IP platform". vccircle.com. 6 November 2013. Retrieved 14 October 2016.
- ^ "Five start-ups that herald the future of biotechnology". livemint.com. 14 May 2014. Retrieved 14 October 2016.
- ^ "Bangalore's Theramyt Is A BioTech Venture Developing Tech Platforms To Generate New Class Cancer Therapies". indianweb2.com. 22 January 2015. Retrieved 14 October 2016.
- ^ Alex, Philippidis (16 August 2016). "Cluster's Mass. Appeal Draws Companies, Jobs". genengnews.com. Retrieved 14 October 2016.